A new genomics system developed to identify interferon-sensitive mutations was used to generate an attenuated hyper-interferon (IFN)-susceptible influenza virus vaccine candidate, which not only elicited robust immune responses but could also be used to produce vaccines against other pathogens, Chinese and U.S. researchers reported in the Jan. 19, 2018, edition of Science.